Corporate Communications and Governance Updates from Chaoju Eye Care Holdings Limited

On 21 April 2026, Chaoju Eye Care Holdings Limited (stock code 02219) issued a series of formal notices that together outline the company’s forthcoming annual general meeting (AGM), its approach to electronic dissemination of corporate information, and its latest reporting on environmental, social, and governance (ESG) matters.

1. Electronic Dissemination of Corporate Communications

The company released a notification letter and a reply form directed at non‑registered shareholders. This communication explains that Chaoju Eye Care will continue to employ an electronic system for distributing key corporate documents—such as annual reports, AGM agendas, and proxy forms—to ensure timely and secure delivery. The notice invites shareholders who are not registered on the exchange’s official system to respond with their preferred method of receipt, thereby expanding accessibility while maintaining compliance with regulatory requirements.

2. Notice of the Annual General Meeting

Shortly thereafter, a formal notice was published announcing the AGM. The meeting is scheduled for a date that will be confirmed in subsequent correspondence, but the notice confirms that shareholders will be invited to vote on the company’s 2025 financial performance and future strategy. As is customary, the notice includes a brief overview of the agenda items, which are expected to cover the appointment of directors, remuneration of executives, and approval of the annual report.

3. Proxy Form for AGM Participation

Alongside the AGM notice, the company provided a proxy form. This document allows shareholders to delegate their voting rights to a designated proxy if they are unable to attend the meeting in person. The form outlines the procedures for submitting proxies electronically and emphasizes the importance of timely submission to guarantee representation at the AGM.

4. ESG Report 2025

A significant component of the company’s disclosure package is the 2025 ESG report. This document offers a comprehensive view of Chaoju Eye Care’s environmental stewardship, social responsibility, and governance practices. Key highlights include:

  • Environmental: Initiatives to reduce carbon emissions in ophthalmology clinics and the integration of sustainable materials in optical products.
  • Social: Programs aimed at improving eye‑health awareness in underserved communities, especially in Hong Kong where the company operates its services.
  • Governance: Strengthening of board oversight and adherence to Hong Kong Stock Exchange listing rules.

The ESG report not only satisfies regulatory demands but also signals Chaoju Eye Care’s commitment to responsible business practices—a factor increasingly important to investors and patients alike.

5. Annual Report 2025

Finally, the company published its Annual Report for 2025. This comprehensive financial statement details the company’s performance in the health‑care sector, with a focus on ophthalmology services such as refractive correction and myopia prevention. The report confirms a modest rise in market cap to HKD 1.98 billion, a price‑earnings ratio of 9.53, and a closing share price of HKD 2.86 as of 19 April 2026. The report also outlines strategic plans to expand service offerings across Hong Kong and to enhance the patient experience through technology integration.

These coordinated releases illustrate Chaoju Eye Care Holdings Limited’s proactive governance and its dedication to transparency. Shareholders and stakeholders are now equipped with the necessary documents to engage fully in the company’s decision‑making processes, while the ESG and annual reports provide insight into the firm’s operational health and long‑term sustainability initiatives.